The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free tumor DNA and TERT promoter mutations in bladder cancer.
 
Franklin W. Huang
No Relationships to Disclose
 
Mikael L. Rinne
No Relationships to Disclose
 
Kevin T. Lundgren
No Relationships to Disclose
 
Stephanie Anne Mullane
No Relationships to Disclose
 
Irene Moreno
No Relationships to Disclose
 
Sarah Reed
No Relationships to Disclose
 
Greg Gydush
No Relationships to Disclose
 
Viktor Adalsteinsson
No Relationships to Disclose
 
Jesse Novak
No Relationships to Disclose
 
William C. Hahn
No Relationships to Disclose
 
Sabina Signoretti
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Levi A. Garraway
Stock and Other Ownership Interests - Foundation Medicine
Honoraria - Bayer
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Novartis; Third Rock Ventures; Warp Drive Bio
Research Funding - Astellas Pharma; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Bayer; Novartis; Wuxi AppTec
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer